基本信息
浏览量:0
职业迁徙
个人简介
My Research
KEYWORDS
cancer, developmental genetics, genome integrity, stem cell biology, self-renewal, differentiation, squamous cell carcinoma, transcriptional networks
SUMMARY
Our laboratory studies how stem cell – like cancer cells drive tumor growth and therapy resistance in patients with squamous cell carcinomas and other epithelial cancers. Our research focusses on two fundamental questions in stem- and cancer cell biology:
1. How do stem cell – like tumor propagating cells self-renew and differentiate?
2. How can stem cell – like cancer cells interconvert between functionally distinctive states?
By elucidating these mechanisms in mouse and patient derived carcinoma models, we are beginning to understand how stem cell – like cancer cells expand indefinitely, how they survive treatment to enable tumor progression after temporary disease containment, and how they initiate metastases in distant organs.
We focus primarily on cutaneous and head and neck squamous cell carcinomas (SCCs). SCCs are amongst the most common human cancers. They are hierarchically organized, maintained by stem cell – like cancer cells, and are often aggressive and therapy resistant. To dissect how stem cell – like SCC cells self-renew and differentiate, and how they resist chemotherapy to drive tumor progression after remission, we develop novel mouse and patient derived SCC models. These models, in combination with innovative fluorescent reporters, allow us to uncover the phenotypic plasticity of stem cell – like SCC cells within intact tumors and delineate the transcriptional networks that define their state transitions in situ.
Our research discovered a SCC specific, bi-stable transcriptional network that governs self-renewal and differentiation of stem cell – like SCC cells. By combining next generation sequencing approaches (RNA-seq, ChIP-seq, ATAC-seq) with gain- and loss-of-function genetics, we discovered the transcription factors SOX2, PITX1 and TP63 co-operatively enhance each other’s transcription in a feed forward circuit that drives self-renewal, while they repress and are repressed by KLF4 dependent differentiation in SCCs. We currently employ proteomic and transcriptomic approaches to explore how the activity of these transcription factors is regulated in SCCs. Our identification of this transcriptional network and its regulation will provide a starting point for the development of differentiation therapies for SCC patients in the future.
We also discovered that SCC cells can periodically interconvert between proliferative and quiescent stem cell – like states. We found the transition from a proliferative to a quiescent stem cell – like state is governed by TGFβ-signaling and it allows stem cell – like SCC cells to survive chemotherapy and become more tumorigenic as a result of treatment failure. Our findings suggest treatment resistance could be predicted prior to treatment and TGFβ-inhibition could sensitize quiescent SCC cells to chemotherapy. We currently investigate how epigenetic differences between functionally distinctive stem cell – like SCC cells influence therapeutic responses, and how chemotherapy affects the epigenetic, functional, and phenotypic plasticity of stem cell – like SCC cells in tumors.
KEYWORDS
cancer, developmental genetics, genome integrity, stem cell biology, self-renewal, differentiation, squamous cell carcinoma, transcriptional networks
SUMMARY
Our laboratory studies how stem cell – like cancer cells drive tumor growth and therapy resistance in patients with squamous cell carcinomas and other epithelial cancers. Our research focusses on two fundamental questions in stem- and cancer cell biology:
1. How do stem cell – like tumor propagating cells self-renew and differentiate?
2. How can stem cell – like cancer cells interconvert between functionally distinctive states?
By elucidating these mechanisms in mouse and patient derived carcinoma models, we are beginning to understand how stem cell – like cancer cells expand indefinitely, how they survive treatment to enable tumor progression after temporary disease containment, and how they initiate metastases in distant organs.
We focus primarily on cutaneous and head and neck squamous cell carcinomas (SCCs). SCCs are amongst the most common human cancers. They are hierarchically organized, maintained by stem cell – like cancer cells, and are often aggressive and therapy resistant. To dissect how stem cell – like SCC cells self-renew and differentiate, and how they resist chemotherapy to drive tumor progression after remission, we develop novel mouse and patient derived SCC models. These models, in combination with innovative fluorescent reporters, allow us to uncover the phenotypic plasticity of stem cell – like SCC cells within intact tumors and delineate the transcriptional networks that define their state transitions in situ.
Our research discovered a SCC specific, bi-stable transcriptional network that governs self-renewal and differentiation of stem cell – like SCC cells. By combining next generation sequencing approaches (RNA-seq, ChIP-seq, ATAC-seq) with gain- and loss-of-function genetics, we discovered the transcription factors SOX2, PITX1 and TP63 co-operatively enhance each other’s transcription in a feed forward circuit that drives self-renewal, while they repress and are repressed by KLF4 dependent differentiation in SCCs. We currently employ proteomic and transcriptomic approaches to explore how the activity of these transcription factors is regulated in SCCs. Our identification of this transcriptional network and its regulation will provide a starting point for the development of differentiation therapies for SCC patients in the future.
We also discovered that SCC cells can periodically interconvert between proliferative and quiescent stem cell – like states. We found the transition from a proliferative to a quiescent stem cell – like state is governed by TGFβ-signaling and it allows stem cell – like SCC cells to survive chemotherapy and become more tumorigenic as a result of treatment failure. Our findings suggest treatment resistance could be predicted prior to treatment and TGFβ-inhibition could sensitize quiescent SCC cells to chemotherapy. We currently investigate how epigenetic differences between functionally distinctive stem cell – like SCC cells influence therapeutic responses, and how chemotherapy affects the epigenetic, functional, and phenotypic plasticity of stem cell – like SCC cells in tumors.
研究兴趣
论文共 4 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 9549-9549
引用0浏览0引用
0
0
Steven Hoang-Phou,Ana Sastre-Perona, Matteo Abbruzzese,Zhe Ying, Jasmin Siegle,Beatriz Aranda Orgilles,Pedro P. Rocha,Iannis Aifantis,Jane Skok,Slobodan Beronja,Markus Schober
biorxiv(2021)
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn